25 XP   0   0   10

Boule Diagnostics AB
Buy, Hold or Sell?

Let's analyse Boule together

PenkeI guess you are interested in Boule Diagnostics AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Boule Diagnostics AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Boule Diagnostics AB

I send you an email if I find something interesting about Boule Diagnostics AB.

Quick analysis of Boule (30 sec.)










What can you expect buying and holding a share of Boule? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
75.0%

What is your share worth?

Current worth
kr12.17
Expected worth in 1 year
kr12.42
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
kr0.26
Return On Investment
2.7%

For what price can you sell your share?

Current Price per Share
kr9.56
Expected price per share
kr8.81 - kr9.96
How sure are you?
50%

1. Valuation of Boule (5 min.)




Live pricePrice per Share (EOD)

kr9.56

Intrinsic Value Per Share

kr-12.92 - kr1.28

Total Value Per Share

kr-0.75 - kr13.45

2. Growth of Boule (5 min.)




Is Boule growing?

Current yearPrevious yearGrowGrow %
How rich?$43.6m$32.5m$11.3m25.8%

How much money is Boule making?

Current yearPrevious yearGrowGrow %
Making money$576.1k$294.7k$281.4k48.8%
Net Profit Margin4.4%2.4%--

How much money comes from the company's main activities?

3. Financial Health of Boule (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#176 / 334

Most Revenue
#174 / 334

Most Profit
#100 / 334

What can you expect buying and holding a share of Boule? (5 min.)

Welcome investor! Boule's management wants to use your money to grow the business. In return you get a share of Boule.

What can you expect buying and holding a share of Boule?

First you should know what it really means to hold a share of Boule. And how you can make/lose money.

Speculation

The Price per Share of Boule is kr9.56. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Boule.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Boule, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr12.17. Based on the TTM, the Book Value Change Per Share is kr0.06 per quarter. Based on the YOY, the Book Value Change Per Share is kr1.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Boule.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.020.2%0.010.2%0.010.1%0.010.1%0.010.1%
Usd Book Value Change Per Share-0.03-0.3%0.010.1%0.111.1%0.020.2%0.020.2%
Usd Dividend Per Share0.000.0%0.000.0%0.020.2%0.010.1%0.010.1%
Usd Total Gains Per Share-0.03-0.3%0.010.1%0.131.3%0.030.3%0.030.3%
Usd Price Per Share1.03-0.99-2.65-3.92-8.22-
Price to Earnings Ratio12.93-18.20-84.52-220.68-173.87-
Price-to-Total Gains Ratio-35.45-46.49-38.25--2,582,063,786,359,317.50--1,291,031,893,179,443.50-
Price to Book Ratio0.92-0.88-3.43-5.38-14.53-
Price-to-Total Gains Ratio-35.45-46.49-38.25--2,582,063,786,359,317.50--1,291,031,893,179,443.50-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.878564
Number of shares1138
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.010.02
Usd Total Gains Per Share0.010.03
Gains per Quarter (1138 shares)6.6737.52
Gains per Year (1138 shares)26.68150.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1027175892140
205344115185290
308071173277440
4010798231370590
50133125288462740
60160152346554890
701871794046471040
802132064617391190
902402335198321340
1002672605779241490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%17.03.00.085.0%36.04.00.090.0%49.010.014.067.1%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%14.06.00.070.0%32.08.00.080.0%44.029.00.060.3%
Dividend per Share0.00.04.00.0%8.00.04.066.7%13.00.07.065.0%30.00.010.075.0%33.00.040.045.2%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%14.06.00.070.0%32.08.00.080.0%45.028.00.061.6%

Fundamentals of Boule

About Boule Diagnostics AB

Boule Diagnostics AB (publ), a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics. The company provides hematology analyzers, reagents, blood controls and calibrators, and reagents rotors, as well as cleaning products under the Swelab, Medonic, CDS, and Quintus brands; and veterinary hematology and clinical chemistry analyzer and diagnostics systems under the Exigo brand. It sells its products directly in Sweden and the United States, as well as through distributors internationally. The company serves hospitals, clinics, laboratories, healthcare centers and veterinary clinics, and other diagnostics companies. It has operations in Sweden, the United States, Mexico, and Russia. The company was founded in 1956 and is headquartered in Spånga, Sweden.

Fundamental data was last updated by Penke on 2024-04-20 01:19:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Boule Diagnostics AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Boule earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Boule to the Medical Devices industry mean.
  • A Net Profit Margin of 5.7% means that kr0.06 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Boule Diagnostics AB:

  • The MRQ is 5.7%. The company is making a profit. +1
  • The TTM is 4.4%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.7%TTM4.4%+1.4%
TTM4.4%YOY2.4%+2.0%
TTM4.4%5Y0.9%+3.5%
5Y0.9%10Y4.6%-3.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7%-12.4%+18.1%
TTM4.4%-20.4%+24.8%
YOY2.4%-14.8%+17.2%
5Y0.9%-21.3%+22.2%
10Y4.6%-25.0%+29.6%
1.1.2. Return on Assets

Shows how efficient Boule is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Boule to the Medical Devices industry mean.
  • 1.1% Return on Assets means that Boule generated kr0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Boule Diagnostics AB:

  • The MRQ is 1.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.8%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.1%TTM0.8%+0.3%
TTM0.8%YOY0.5%+0.3%
TTM0.8%5Y0.3%+0.5%
5Y0.3%10Y1.3%-1.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1%-4.1%+5.2%
TTM0.8%-4.7%+5.5%
YOY0.5%-4.8%+5.3%
5Y0.3%-4.0%+4.3%
10Y1.3%-5.2%+6.5%
1.1.3. Return on Equity

Shows how efficient Boule is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Boule to the Medical Devices industry mean.
  • 1.8% Return on Equity means Boule generated kr0.02 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Boule Diagnostics AB:

  • The MRQ is 1.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.8%TTM1.3%+0.5%
TTM1.3%YOY0.9%+0.4%
TTM1.3%5Y0.5%+0.8%
5Y0.5%10Y2.1%-1.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8%-4.2%+6.0%
TTM1.3%-5.8%+7.1%
YOY0.9%-5.7%+6.6%
5Y0.5%-6.3%+6.8%
10Y2.1%-7.1%+9.2%

1.2. Operating Efficiency of Boule Diagnostics AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Boule is operating .

  • Measures how much profit Boule makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Boule to the Medical Devices industry mean.
  • An Operating Margin of 6.6% means the company generated kr0.07  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Boule Diagnostics AB:

  • The MRQ is 6.6%. The company is operating less efficient.
  • The TTM is 6.7%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ6.6%TTM6.7%-0.1%
TTM6.7%YOY6.6%+0.2%
TTM6.7%5Y5.5%+1.2%
5Y5.5%10Y5.4%+0.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6%-24.3%+30.9%
TTM6.7%-16.4%+23.1%
YOY6.6%-13.7%+20.3%
5Y5.5%-19.9%+25.4%
10Y5.4%-24.5%+29.9%
1.2.2. Operating Ratio

Measures how efficient Boule is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.93 means that the operating costs are kr0.93 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Boule Diagnostics AB:

  • The MRQ is 0.934. The company is less efficient in keeping operating costs low.
  • The TTM is 0.932. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.934TTM0.932+0.001
TTM0.932YOY0.940-0.007
TTM0.9325Y0.937-0.004
5Y0.93710Y0.913+0.023
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9341.442-0.508
TTM0.9321.439-0.507
YOY0.9401.431-0.491
5Y0.9371.436-0.499
10Y0.9131.374-0.461

1.3. Liquidity of Boule Diagnostics AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Boule is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.38 means the company has kr1.38 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Boule Diagnostics AB:

  • The MRQ is 1.379. The company is just able to pay all its short-term debts.
  • The TTM is 1.478. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.379TTM1.478-0.100
TTM1.478YOY1.185+0.293
TTM1.4785Y1.299+0.179
5Y1.29910Y1.574-0.275
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3792.726-1.347
TTM1.4782.732-1.254
YOY1.1853.510-2.325
5Y1.2993.617-2.318
10Y1.5743.499-1.925
1.3.2. Quick Ratio

Measures if Boule is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Boule to the Medical Devices industry mean.
  • A Quick Ratio of 1.07 means the company can pay off kr1.07 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Boule Diagnostics AB:

  • The MRQ is 1.071. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.954. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.071TTM0.954+0.118
TTM0.954YOY0.797+0.157
TTM0.9545Y0.862+0.092
5Y0.86210Y1.077-0.216
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0711.491-0.420
TTM0.9541.633-0.679
YOY0.7972.113-1.316
5Y0.8622.295-1.433
10Y1.0772.255-1.178

1.4. Solvency of Boule Diagnostics AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Boule assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Boule to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.37 means that Boule assets are financed with 37.1% credit (debt) and the remaining percentage (100% - 37.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Boule Diagnostics AB:

  • The MRQ is 0.371. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.381. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.371TTM0.381-0.010
TTM0.381YOY0.480-0.099
TTM0.3815Y0.446-0.065
5Y0.44610Y0.409+0.038
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3710.389-0.018
TTM0.3810.386-0.005
YOY0.4800.335+0.145
5Y0.4460.442+0.004
10Y0.4090.461-0.052
1.4.2. Debt to Equity Ratio

Measures if Boule is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Boule to the Medical Devices industry mean.
  • A Debt to Equity ratio of 58.9% means that company has kr0.59 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Boule Diagnostics AB:

  • The MRQ is 0.589. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.616. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.589TTM0.616-0.026
TTM0.616YOY0.941-0.325
TTM0.6165Y0.818-0.203
5Y0.81810Y0.707+0.112
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5890.551+0.038
TTM0.6160.554+0.062
YOY0.9410.479+0.462
5Y0.8180.622+0.196
10Y0.7070.674+0.033

2. Market Valuation of Boule Diagnostics AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Boule generates.

  • Above 15 is considered overpriced but always compare Boule to the Medical Devices industry mean.
  • A PE ratio of 12.93 means the investor is paying kr12.93 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Boule Diagnostics AB:

  • The EOD is 11.013. Based on the earnings, the company is underpriced. +1
  • The MRQ is 12.926. Based on the earnings, the company is underpriced. +1
  • The TTM is 18.199. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD11.013MRQ12.926-1.912
MRQ12.926TTM18.199-5.273
TTM18.199YOY84.524-66.325
TTM18.1995Y220.678-202.479
5Y220.67810Y173.866+46.812
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD11.013-1.077+12.090
MRQ12.926-1.704+14.630
TTM18.199-2.081+20.280
YOY84.524-2.978+87.502
5Y220.678-2.379+223.057
10Y173.866-1.726+175.592
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Boule Diagnostics AB:

  • The EOD is 11.969. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 14.047. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 5.477. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD11.969MRQ14.047-2.078
MRQ14.047TTM5.477+8.570
TTM5.477YOY-19.067+24.544
TTM5.4775Y-14.026+19.504
5Y-14.02610Y45.769-59.795
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD11.969-0.932+12.901
MRQ14.047-1.578+15.625
TTM5.477-2.973+8.450
YOY-19.067-6.318-12.749
5Y-14.026-5.307-8.719
10Y45.769-5.171+50.940
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Boule is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.92 means the investor is paying kr0.92 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Boule Diagnostics AB:

  • The EOD is 0.786. Based on the equity, the company is cheap. +2
  • The MRQ is 0.922. Based on the equity, the company is cheap. +2
  • The TTM is 0.880. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.786MRQ0.922-0.136
MRQ0.922TTM0.880+0.042
TTM0.880YOY3.432-2.552
TTM0.8805Y5.382-4.502
5Y5.38210Y14.529-9.146
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.7861.876-1.090
MRQ0.9222.372-1.450
TTM0.8802.434-1.554
YOY3.4323.217+0.215
5Y5.3823.893+1.489
10Y14.5294.245+10.284
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Boule Diagnostics AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.3160.064-596%1.157-127%0.221-243%0.222-243%
Book Value Per Share--12.16512.266-1%9.113+33%8.930+36%7.241+68%
Current Ratio--1.3791.478-7%1.185+16%1.299+6%1.574-12%
Debt To Asset Ratio--0.3710.381-3%0.480-23%0.446-17%0.409-9%
Debt To Equity Ratio--0.5890.616-4%0.941-37%0.818-28%0.707-17%
Dividend Per Share----0%0.207-100%0.138-100%0.105-100%
Eps--0.2170.161+35%0.083+163%0.064+237%0.135+61%
Free Cash Flow Per Share--0.200-0.202+201%-0.563+382%-0.124+162%-0.032+116%
Free Cash Flow To Equity Per Share---0.364-0.365+0%0.342-206%0.040-1010%0.046-888%
Gross Profit Margin---2.868-4.337+51%-8.167+185%-10.486+266%-6.516+127%
Intrinsic Value_10Y_max--1.284--------
Intrinsic Value_10Y_min---12.920--------
Intrinsic Value_1Y_max---0.091--------
Intrinsic Value_1Y_min---1.166--------
Intrinsic Value_3Y_max---0.107--------
Intrinsic Value_3Y_min---3.636--------
Intrinsic Value_5Y_max--0.080--------
Intrinsic Value_5Y_min---6.232--------
Market Cap371244436.000-18%438281250.000419361399.660+5%1118393280.000-61%1660844063.182-74%3477325057.774-87%
Net Profit Margin--0.0570.044+31%0.024+143%0.009+530%0.046+25%
Operating Margin--0.0660.067-2%0.066+1%0.055+19%0.054+24%
Operating Ratio--0.9340.932+0%0.940-1%0.9370%0.913+2%
Pb Ratio0.786-17%0.9220.880+5%3.432-73%5.382-83%14.529-94%
Pe Ratio11.013-17%12.92618.199-29%84.524-85%220.678-94%173.866-93%
Price Per Share9.560-17%11.22010.783+4%28.800-61%42.654-74%89.488-87%
Price To Free Cash Flow Ratio11.969-17%14.0475.477+156%-19.067+236%-14.026+200%45.769-69%
Price To Total Gains Ratio-30.205+15%-35.45046.488-176%38.251-193%-2582063786359317.500+7283600952069486%-1291031893179443.500+3641800476034085%
Quick Ratio--1.0710.954+12%0.797+34%0.862+24%1.077-1%
Return On Assets--0.0110.008+37%0.005+132%0.003+263%0.013-16%
Return On Equity--0.0180.013+35%0.009+88%0.005+239%0.021-16%
Total Gains Per Share---0.3160.064-596%1.364-123%0.359-188%0.327-197%
Usd Book Value--43670880.00043838597.5000%32523501.900+34%31940823.735+37%25877675.285+69%
Usd Book Value Change Per Share---0.0290.006-596%0.106-127%0.020-243%0.020-243%
Usd Book Value Per Share--1.1181.127-1%0.838+33%0.821+36%0.665+68%
Usd Dividend Per Share----0%0.019-100%0.013-100%0.010-100%
Usd Eps--0.0200.015+35%0.008+163%0.006+237%0.012+61%
Usd Free Cash Flow--716820.000-721415.000+201%-2008336.650+380%-442130.900+162%-111961.770+116%
Usd Free Cash Flow Per Share--0.018-0.019+201%-0.052+382%-0.011+162%-0.003+116%
Usd Free Cash Flow To Equity Per Share---0.033-0.034+0%0.031-206%0.004-1010%0.004-888%
Usd Market Cap34117363.668-18%40278046.87538539312.629+5%102780342.432-61%152631569.406-74%319566172.809-87%
Usd Price Per Share0.879-17%1.0310.991+4%2.647-61%3.920-74%8.224-87%
Usd Profit--779036.300576144.075+35%294723.300+164%233237.605+234%484035.003+61%
Usd Revenue--13610390.00013127915.000+4%12594619.300+8%11377707.070+20%10033706.330+36%
Usd Total Gains Per Share---0.0290.006-596%0.125-123%0.033-188%0.030-197%
 EOD+5 -3MRQTTM+20 -14YOY+23 -135Y+24 -1210Y+20 -16

3.2. Fundamental Score

Let's check the fundamental score of Boule Diagnostics AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1511.013
Price to Book Ratio (EOD)Between0-10.786
Net Profit Margin (MRQ)Greater than00.057
Operating Margin (MRQ)Greater than00.066
Quick Ratio (MRQ)Greater than11.071
Current Ratio (MRQ)Greater than11.379
Debt to Asset Ratio (MRQ)Less than10.371
Debt to Equity Ratio (MRQ)Less than10.589
Return on Equity (MRQ)Greater than0.150.018
Return on Assets (MRQ)Greater than0.050.011
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Boule Diagnostics AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.168
Ma 20Greater thanMa 509.689
Ma 50Greater thanMa 1009.766
Ma 100Greater thanMa 20010.332
OpenGreater thanClose9.760
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets755,100
Total Liabilities279,900
Total Stockholder Equity475,100
 As reported
Total Liabilities 279,900
Total Stockholder Equity+ 475,100
Total Assets = 755,100

Assets

Total Assets755,100
Total Current Assets279,900
Long-term Assets475,200
Total Current Assets
Cash And Cash Equivalents 37,300
Net Receivables 180,200
Inventory 62,400
Total Current Assets  (as reported)279,900
Total Current Assets  (calculated)279,900
+/-0
Long-term Assets
Property Plant Equipment 44,300
Goodwill 85,400
Intangible Assets 293,598
Long-term Assets Other 1
Long-term Assets  (as reported)475,200
Long-term Assets  (calculated)423,299
+/- 51,901

Liabilities & Shareholders' Equity

Total Current Liabilities203,000
Long-term Liabilities76,900
Total Stockholder Equity475,100
Total Current Liabilities
Short-term Debt 97,500
Short Long Term Debt 84,522
Accounts payable 35,700
Other Current Liabilities 63,900
Total Current Liabilities  (as reported)203,000
Total Current Liabilities  (calculated)281,622
+/- 78,622
Long-term Liabilities
Long term Debt 57,744
Capital Lease Obligations 23,907
Long-term Liabilities Other 1
Long-term Liabilities  (as reported)76,900
Long-term Liabilities  (calculated)81,652
+/- 4,752
Total Stockholder Equity
Common Stock9,700
Retained Earnings 98,500
Accumulated Other Comprehensive Income 30,700
Other Stockholders Equity 336,200
Total Stockholder Equity (as reported)475,100
Total Stockholder Equity (calculated)475,100
+/-0
Other
Capital Stock9,708
Cash and Short Term Investments 37,300
Common Stock Shares Outstanding 39,063
Current Deferred Revenue5,900
Liabilities and Stockholders Equity 755,100
Net Debt 128,800
Net Invested Capital 617,362
Net Working Capital 76,932
Property Plant and Equipment Gross 173,292
Short Long Term Debt Total 166,100



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-31
> Total Assets 
174,631
172,169
160,745
166,920
165,418
170,240
191,790
176,664
171,617
163,656
158,481
161,387
168,361
170,422
163,442
165,123
149,368
151,844
162,780
166,111
206,113
206,088
275,812
263,481
271,847
240,992
254,143
251,803
275,231
283,247
312,221
224,019
220,718
217,100
238,300
257,600
279,949
289,400
286,800
291,300
315,483
282,800
308,500
341,600
364,333
378,200
376,500
395,100
416,491
421,300
436,900
435,400
500,848
554,000
554,700
597,200
586,867
627,700
565,100
557,100
479,710
514,400
525,400
541,200
572,030
609,300
643,500
692,200
759,964
764,000
778,700
784,700
755,100
755,100784,700778,700764,000759,964692,200643,500609,300572,030541,200525,400514,400479,710557,100565,100627,700586,867597,200554,700554,000500,848435,400436,900421,300416,491395,100376,500378,200364,333341,600308,500282,800315,483291,300286,800289,400279,949257,600238,300217,100220,718224,019312,221283,247275,231251,803254,143240,992271,847263,481275,812206,088206,113166,111162,780151,844149,368165,123163,442170,422168,361161,387158,481163,656171,617176,664191,790170,240165,418166,920160,745172,169174,631
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
102,045
99,854
162,317
140,734
151,547
114,948
116,074
110,600
123,501
123,442
144,951
131,207
121,051
114,400
130,100
141,100
150,499
150,900
151,300
162,800
165,616
135,000
161,200
195,900
211,574
226,100
228,900
246,800
264,270
261,600
233,100
229,600
221,913
227,100
220,400
242,300
226,802
253,800
235,900
234,800
196,619
217,300
223,900
228,100
242,375
258,800
263,800
288,500
338,414
333,500
327,000
310,500
279,900
279,900310,500327,000333,500338,414288,500263,800258,800242,375228,100223,900217,300196,619234,800235,900253,800226,802242,300220,400227,100221,913229,600233,100261,600264,270246,800228,900226,100211,574195,900161,200135,000165,616162,800151,300150,900150,499141,100130,100114,400121,051131,207144,951123,442123,501110,600116,074114,948151,547140,734162,31799,854102,04500000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,689
13,758
12,092
41,844
53,701
21,158
16,942
16,058
15,871
15,815
19,318
20,289
11,051
11,600
23,400
24,800
22,656
19,500
17,600
19,100
50,395
19,100
16,600
37,000
44,588
65,900
66,600
74,600
99,163
104,700
61,900
39,100
30,256
16,800
17,000
19,200
21,580
26,600
35,700
39,600
32,989
31,500
27,700
35,700
38,183
36,200
40,500
39,400
96,904
62,600
45,900
52,900
37,300
37,30052,90045,90062,60096,90439,40040,50036,20038,18335,70027,70031,50032,98939,60035,70026,60021,58019,20017,00016,80030,25639,10061,900104,70099,16374,60066,60065,90044,58837,00016,60019,10050,39519,10017,60019,50022,65624,80023,40011,60011,05120,28919,31815,81515,87116,05816,94221,15853,70141,84412,09213,75817,68900000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-46,500
-47,600
-50,500
0
0-50,500-47,600-46,50000000000000000000000045,10000000000000000000000000000000000000000000000000
       Net Receivables 
25,815
30,184
26,206
36,353
33,292
30,359
36,615
34,559
37,382
32,670
33,253
37,975
32,500
37,701
34,511
37,814
24,643
34,312
35,027
34,954
43,584
45,710
104,242
50,614
49,692
45,220
50,362
45,054
59,338
54,852
64,869
53,801
57,882
51,800
56,200
63,000
61,441
74,700
76,600
78,100
56,989
65,400
84,900
97,000
101,203
92,100
95,200
109,700
110,514
101,900
112,100
124,900
123,890
124,000
116,000
129,100
136,982
146,700
124,100
127,800
99,844
116,400
121,500
122,300
127,886
137,500
139,000
134,000
143,569
190,100
197,900
182,200
180,200
180,200182,200197,900190,100143,569134,000139,000137,500127,886122,300121,500116,40099,844127,800124,100146,700136,982129,100116,000124,000123,890124,900112,100101,900110,514109,70095,20092,100101,20397,00084,90065,40056,98978,10076,60074,70061,44163,00056,20051,80057,88253,80164,86954,85259,33845,05450,36245,22049,69250,614104,24245,71043,58434,95435,02734,31224,64337,81434,51137,70132,50037,97533,25332,67037,38234,55936,61530,35933,29236,35326,20630,18425,815
       Other Current Assets 
1,810
0
0
0
1,168
0
1
0
1,410
1
1
0
1,574
1
2
0
3,320
0
0
0
46,072
47,439
110,210
54,623
54,467
48,082
53,572
48,464
61,994
58,901
73,572
58,779
62,146
56,700
59,500
67,800
81,647
83,000
79,100
85,200
60,460
68,400
92,400
105,300
107,800
96,400
107,100
77,300
114,348
110,500
117,300
137,800
133,631
148,200
144,800
161,800
147,631
162,000
130,600
139,500
109,088
134,700
137,300
134,500
145,154
153,200
100
-100
1
100
-200
-100
-2
-2-100-2001001-100100153,200145,154134,500137,300134,700109,088139,500130,600162,000147,631161,800144,800148,200133,631137,800117,300110,500114,34877,300107,10096,400107,800105,30092,40068,40060,46085,20079,10083,00081,64767,80059,50056,70062,14658,77973,57258,90161,99448,46453,57248,08254,46754,623110,21047,43946,0720003,3200211,5740111,4100101,1680001,810
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
104,068
106,234
113,495
122,747
120,300
126,044
138,069
141,203
151,730
159,805
167,270
92,812
99,667
102,700
108,300
116,500
129,450
138,500
135,600
128,500
149,867
147,800
147,300
145,700
152,759
152,100
147,600
148,300
152,221
159,700
203,800
205,700
278,935
327,000
334,300
354,900
360,065
373,900
329,200
322,300
283,091
297,100
301,500
313,200
329,655
350,500
379,800
403,600
421,550
430,500
451,700
474,100
475,200
475,200474,100451,700430,500421,550403,600379,800350,500329,655313,200301,500297,100283,091322,300329,200373,900360,065354,900334,300327,000278,935205,700203,800159,700152,221148,300147,600152,100152,759145,700147,300147,800149,867128,500135,600138,500129,450116,500108,300102,70099,66792,812167,270159,805151,730141,203138,069126,044120,300122,747113,495106,234104,06800000000000000000000
       Property Plant Equipment 
8,596
8,169
7,767
7,036
7,972
8,396
7,957
7,045
8,172
7,906
7,739
8,207
8,034
8,845
8,082
7,464
6,863
6,824
7,458
7,570
8,973
8,549
9,549
10,055
12,225
13,244
15,360
15,076
15,316
15,506
15,965
14,847
15,776
15,700
15,800
17,400
17,647
17,700
17,900
17,900
20,329
19,800
20,900
21,200
20,481
19,100
18,800
17,300
16,649
16,800
17,200
19,200
23,121
62,600
59,800
70,200
70,351
68,600
64,200
59,700
54,745
55,200
51,600
49,700
47,424
44,000
42,200
43,700
58,037
53,900
54,400
54,700
44,300
44,30054,70054,40053,90058,03743,70042,20044,00047,42449,70051,60055,20054,74559,70064,20068,60070,35170,20059,80062,60023,12119,20017,20016,80016,64917,30018,80019,10020,48121,20020,90019,80020,32917,90017,90017,70017,64717,40015,80015,70015,77614,84715,96515,50615,31615,07615,36013,24412,22510,0559,5498,5498,9737,5707,4586,8246,8637,4648,0828,8458,0348,2077,7397,9068,1727,0457,9578,3967,9727,0367,7678,1698,596
       Goodwill 
82,536
0
0
0
77,434
0
0
0
72,333
0
0
0
69,955
68,761
67,569
66,376
61,258
59,950
63,946
65,302
63,526
60,145
60,186
63,898
64,344
62,297
64,613
61,671
61,584
61,588
62,924
61,002
61,535
61,600
63,100
66,500
70,355
75,800
73,200
74,300
74,015
72,600
74,900
75,800
79,054
77,900
74,800
72,400
73,201
74,100
78,100
77,400
78,201
80,300
80,200
83,800
80,543
85,700
80,800
78,300
72,906
76,500
75,100
77,000
78,693
80,200
86,600
92,800
88,123
87,600
90,900
90,900
85,400
85,40090,90090,90087,60088,12392,80086,60080,20078,69377,00075,10076,50072,90678,30080,80085,70080,54383,80080,20080,30078,20177,40078,10074,10073,20172,40074,80077,90079,05475,80074,90072,60074,01574,30073,20075,80070,35566,50063,10061,60061,53561,00262,92461,58861,58461,67164,61362,29764,34463,89860,18660,14563,52665,30263,94659,95061,25866,37667,56968,76169,95500072,33300077,43400082,536
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,121
0
0
0
0
0
0
0
55,835
51,700
48,700
46,700
43,200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000043,20046,70048,70051,70055,835000000028,12100000000000000000000000000000000000000000000
       Intangible Assets 
82,536
81,742
80,423
79,103
77,434
76,465
75,145
73,827
72,333
71,188
69,869
68,550
69,955
68,761
67,569
66,376
61,258
59,950
63,946
65,302
63,526
60,145
30,603
35,728
42,592
62,297
121,338
61,671
73,879
81,358
86,606
4,747
12,126
15,100
19,100
22,200
28,308
32,400
32,100
28,500
27,668
26,800
26,200
25,600
24,632
24,400
25,300
26,600
30,630
35,600
63,500
68,300
80,657
89,900
100,500
109,000
118,597
128,500
137,900
144,200
115,625
128,100
139,600
149,100
162,885
179,300
198,100
211,600
225,235
238,700
255,500
275,200
293,598
293,598275,200255,500238,700225,235211,600198,100179,300162,885149,100139,600128,100115,625144,200137,900128,500118,597109,000100,50089,90080,65768,30063,50035,60030,63026,60025,30024,40024,63225,60026,20026,80027,66828,50032,10032,40028,30822,20019,10015,10012,1264,74786,60681,35873,87961,671121,33862,29742,59235,72830,60360,14563,52665,30263,94659,95061,25866,37667,56968,76169,95568,55069,86971,18872,33373,82775,14576,46577,43479,10380,42381,74282,536
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,108
4,880
4,204
4,092
0
0
0
0
0
0
0
0
205
200
200
200
47
100
0
-100
18,632
19,500
19,900
22,600
28,137
30,000
28,500
31,800
31,485
33,200
45,000
40,800
96,956
94,200
93,800
91,900
90,574
91,100
46,300
40,100
39,815
37,300
35,200
37,400
40,653
47,000
52,900
55,500
50,155
50,300
50,900
53,300
1
153,30050,90050,30050,15555,50052,90047,00040,65337,40035,20037,30039,81540,10046,30091,10090,57491,90093,80094,20096,95640,80045,00033,20031,48531,80028,50030,00028,13722,60019,90019,50018,632-100010047200200200205000000004,0924,2044,8804,10800000000000000000000
> Total Liabilities 
42,270
41,467
36,555
43,504
46,339
54,507
59,952
46,637
51,293
46,900
43,696
43,683
53,144
55,687
50,689
53,665
48,474
51,372
51,503
54,680
75,548
77,269
93,898
73,580
78,989
49,041
54,169
55,319
75,536
85,222
108,479
95,522
93,226
85,600
104,600
109,100
109,957
103,600
105,600
103,600
126,969
90,300
106,200
118,400
134,568
141,500
152,700
148,000
154,725
143,000
146,700
136,600
199,992
239,600
251,000
263,800
253,997
274,500
267,400
243,700
210,406
236,900
263,100
267,200
276,295
305,600
330,500
355,800
297,460
296,700
297,800
300,000
279,900
279,900300,000297,800296,700297,460355,800330,500305,600276,295267,200263,100236,900210,406243,700267,400274,500253,997263,800251,000239,600199,992136,600146,700143,000154,725148,000152,700141,500134,568118,400106,20090,300126,969103,600105,600103,600109,957109,100104,60085,60093,22695,522108,47985,22275,53655,31954,16949,04178,98973,58093,89877,26975,54854,68051,50351,37248,47453,66550,68955,68753,14443,68343,69646,90051,29346,63759,95254,50746,33943,50436,55541,46742,270
   > Total Current Liabilities 
31,657
0
0
0
40,273
0
0
0
48,181
0
0
0
52,345
28,322
23,969
30,768
47,303
19,551
17,439
0
62,859
63,793
79,137
63,240
74,565
42,897
45,423
45,014
63,444
71,485
94,807
87,439
79,144
71,900
90,000
93,400
99,578
92,900
95,200
93,600
111,423
70,300
82,500
92,100
104,184
108,000
116,900
108,000
118,626
109,400
108,700
111,800
170,819
174,400
178,900
185,800
169,308
184,600
169,800
164,900
152,733
175,600
202,300
192,800
211,202
239,400
273,100
285,400
201,034
207,700
209,600
226,800
203,000
203,000226,800209,600207,700201,034285,400273,100239,400211,202192,800202,300175,600152,733164,900169,800184,600169,308185,800178,900174,400170,819111,800108,700109,400118,626108,000116,900108,000104,18492,10082,50070,300111,42393,60095,20092,90099,57893,40090,00071,90079,14487,43994,80771,48563,44445,01445,42342,89774,56563,24079,13763,79362,859017,43919,55147,30330,76823,96928,32252,34500048,18100040,27300031,657
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,180
25,487
37,923
31,301
36,239
6,781
4,203
4,616
20,195
27,787
38,515
43,887
37,944
34,000
40,300
49,900
41,825
43,300
46,400
37,800
54,876
15,200
13,500
33,100
30,364
33,500
37,900
34,500
38,678
46,700
29,800
31,400
62,590
96,700
100,400
97,300
92,844
91,200
89,700
91,800
83,856
84,400
99,500
96,300
104,753
121,700
171,100
186,000
105,069
104,900
107,400
125,800
97,500
97,500125,800107,400104,900105,069186,000171,100121,700104,75396,30099,50084,40083,85691,80089,70091,20092,84497,300100,40096,70062,59031,40029,80046,70038,67834,50037,90033,50030,36433,10013,50015,20054,87637,80046,40043,30041,82549,90040,30034,00037,94443,88738,51527,78720,1954,6164,2036,78136,23931,30137,92325,48720,18000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
57,290
61,200
67,000
34,500
37,352
32,600
29,100
30,600
61,658
84,800
88,500
85,500
80,155
78,500
77,100
79,200
71,547
71,800
86,800
83,600
92,050
110,300
161,800
177,800
91,698
91,700
93,700
112,200
84,522
84,522112,20093,70091,70091,698177,800161,800110,30092,05083,60086,80071,80071,54779,20077,10078,50080,15585,50088,50084,80061,65830,60029,10032,60037,35234,50067,00061,20057,29000000000000000000000000000000000000000000000
       Accounts payable 
7,198
0
0
0
11,040
0
0
0
11,318
0
0
0
11,237
0
0
0
8,257
0
0
0
15,463
16,053
19,572
11,616
15,133
16,227
14,871
17,071
15,486
15,065
17,784
13,803
14,682
13,700
17,100
10,600
20,998
15,900
16,900
21,900
18,064
13,100
17,300
17,500
21,936
19,300
21,800
21,600
24,475
19,300
25,000
26,100
35,270
23,800
24,000
29,700
30,130
44,800
31,500
29,100
29,352
38,600
43,400
41,900
41,165
58,100
49,000
34,900
33,321
41,600
37,000
43,600
35,700
35,70043,60037,00041,60033,32134,90049,00058,10041,16541,90043,40038,60029,35229,10031,50044,80030,13029,70024,00023,80035,27026,10025,00019,30024,47521,60021,80019,30021,93617,50017,30013,10018,06421,90016,90015,90020,99810,60017,10013,70014,68213,80317,78415,06515,48617,07114,87116,22715,13311,61619,57216,05315,4630008,25700011,23700011,31800011,0400007,198
       Other Current Liabilities 
16,953
0
0
0
15,438
0
0
0
15,847
0
0
0
17,976
28,322
23,969
30,768
19,776
0
0
0
27,216
22,253
21,642
20,323
23,193
19,889
26,349
23,327
27,763
28,633
38,508
29,749
26,518
24,200
32,600
32,900
36,755
33,700
31,900
33,900
38,483
42,000
51,700
41,500
51,884
55,200
57,200
51,900
55,473
43,400
53,900
54,300
72,959
53,900
54,500
58,800
46,334
48,600
48,600
44,000
39,525
52,600
59,400
48,300
54,105
59,600
53,000
64,500
62,644
61,200
19,300
15,300
63,900
63,90015,30019,30061,20062,64464,50053,00059,60054,10548,30059,40052,60039,52544,00048,60048,60046,33458,80054,50053,90072,95954,30053,90043,40055,47351,90057,20055,20051,88441,50051,70042,00038,48333,90031,90033,70036,75532,90032,60024,20026,51829,74938,50828,63327,76323,32726,34919,88923,19320,32321,64222,25327,21600019,77630,76823,96928,32217,97600015,84700015,43800016,953
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,689
13,476
14,761
10,340
4,424
6,144
8,746
10,305
12,092
13,737
13,672
8,083
14,082
13,700
14,600
15,700
10,379
10,700
10,400
10,000
15,546
20,000
23,700
26,300
30,384
33,500
35,800
40,000
36,099
33,600
38,000
24,800
29,173
65,200
72,100
78,000
84,689
89,900
97,600
78,800
57,673
61,300
60,800
74,400
65,093
66,200
57,400
70,400
96,426
89,000
88,200
73,200
76,900
76,90073,20088,20089,00096,42670,40057,40066,20065,09374,40060,80061,30057,67378,80097,60089,90084,68978,00072,10065,20029,17324,80038,00033,60036,09940,00035,80033,50030,38426,30023,70020,00015,54610,00010,40010,70010,37915,70014,60013,70014,0828,08313,67213,73712,09210,3058,7466,1444,42410,34014,76113,47612,68900000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41,630
43,000
41,100
53,100
50,600
52,300
45,700
59,200
84,899
77,000
77,300
61,900
0
061,90077,30077,00084,89959,20045,70052,30050,60053,10041,10043,00041,630000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
200
0
0
-100
-100
0
1
-100
0
-200
0
0
-100
0
0
100
-100
100
1
1100-10010000-10000-2000-10010-100-1000020010000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,632
24,400
25,300
26,600
30,630
35,600
63,500
68,300
80,657
89,900
100,500
109,000
118,597
128,500
137,900
144,200
115,625
128,100
139,600
149,100
162,885
179,300
198,100
211,600
225,200
0
0
0
0
0000225,200211,600198,100179,300162,885149,100139,600128,100115,625144,200137,900128,500118,597109,000100,50089,90080,65768,30063,50035,60030,63026,60025,30024,40024,63200000000000000000000000000000000000000000000
> Total Stockholder Equity
132,362
130,702
124,190
123,416
119,078
115,733
131,838
130,027
120,324
116,756
114,785
117,704
115,218
114,735
112,753
111,458
100,895
100,472
111,277
111,431
130,565
128,819
181,914
189,901
192,858
186,867
199,974
196,484
199,695
198,025
203,742
128,497
127,492
131,500
133,700
148,500
169,992
185,800
181,200
187,700
188,514
192,500
202,300
223,200
229,765
236,700
223,800
247,100
261,766
278,300
290,200
298,800
300,856
314,400
303,700
333,400
332,870
353,200
297,700
313,400
269,304
277,500
262,300
274,000
295,735
303,700
313,000
336,400
462,504
467,300
480,900
484,700
475,100
475,100484,700480,900467,300462,504336,400313,000303,700295,735274,000262,300277,500269,304313,400297,700353,200332,870333,400303,700314,400300,856298,800290,200278,300261,766247,100223,800236,700229,765223,200202,300192,500188,514187,700181,200185,800169,992148,500133,700131,500127,492128,497203,742198,025199,695196,484199,974186,867192,858189,901181,914128,819130,565111,431111,277100,472100,895111,458112,753114,735115,218117,704114,785116,756120,324130,027131,838115,733119,078123,416124,190130,702132,362
   Common Stock
2,519
2,519
2,519
2,519
2,519
115,733
113,056
130,027
3,464
116,756
114,785
117,704
3,464
114,735
112,753
111,458
3,464
100,472
111,277
111,431
3,464
3,464
3,464
4,707
4,707
4,707
4,707
4,707
4,707
4,707
4,707
4,707
4,707
4,700
4,700
4,700
4,707
4,700
4,700
4,700
4,707
4,700
4,700
4,700
4,707
4,700
4,700
4,800
4,854
4,900
4,900
4,900
4,854
4,900
4,900
4,900
4,854
4,900
4,900
4,900
4,854
4,900
4,900
4,900
4,854
4,900
4,900
4,900
9,708
9,700
9,700
9,700
9,700
9,7009,7009,7009,7009,7084,9004,9004,9004,8544,9004,9004,9004,8544,9004,9004,9004,8544,9004,9004,9004,8544,9004,9004,9004,8544,8004,7004,7004,7074,7004,7004,7004,7074,7004,7004,7004,7074,7004,7004,7004,7074,7074,7074,7074,7074,7074,7074,7074,7074,7073,4643,4643,464111,431111,277100,4723,464111,458112,753114,7353,464117,704114,785116,7563,464130,027113,056115,7332,5192,5192,5192,5192,519
   Retained Earnings 
5,392
3,733
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-7,139
-2,437
-2,266
840
-2,948
5,084
9,740
10,640
13,908
12,224
16,379
-56,036
-57,957
-53,700
-51,600
-42,400
-27,456
-20,900
-18,500
-13,600
-12,340
-6,100
2,900
22,200
16,630
25,500
17,800
39,500
47,225
64,000
69,200
79,000
79,991
89,800
79,400
99,700
106,880
114,300
71,300
91,500
58,914
59,200
47,100
54,300
71,507
76,100
68,300
70,700
73,556
81,400
85,500
90,100
98,500
98,50090,10085,50081,40073,55670,70068,30076,10071,50754,30047,10059,20058,91491,50071,300114,300106,88099,70079,40089,80079,99179,00069,20064,00047,22539,50017,80025,50016,63022,2002,900-6,100-12,340-13,600-18,500-20,900-27,456-42,400-51,600-53,700-57,957-56,03616,37912,22413,90810,6409,7405,084-2,948840-2,266-2,437-7,1390000000000000000003,7335,392
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
201,662
201,700
201,600
202,400
202,400
202,400
202,400
202,400
202,400
202,400
202,400
202,400
336,763
336,200
336,200
336,200
0
0336,200336,200336,200336,763202,400202,400202,400202,400202,400202,400202,400202,400202,400201,600201,700201,66200000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
134,240
127,792
180,716
184,354
191,099
182,160
185,527
181,137
181,080
181,094
182,656
179,826
180,742
180,500
180,600
186,200
192,741
202,000
195,000
196,600
196,147
193,900
194,700
196,300
208,428
206,500
201,300
202,800
209,687
209,400
216,100
214,900
216,011
219,700
219,400
228,800
221,136
234,000
221,500
217,000
205,536
213,400
210,300
214,800
219,374
222,700
239,800
260,800
379,240
336,200
336,200
336,200
336,200
336,200336,200336,200336,200379,240260,800239,800222,700219,374214,800210,300213,400205,536217,000221,500234,000221,136228,800219,400219,700216,011214,900216,100209,400209,687202,800201,300206,500208,428196,300194,700193,900196,147196,600195,000202,000192,741186,200180,600180,500180,742179,826182,656181,094181,080181,137185,527182,160191,099184,354180,716127,792134,24000000000000000000000



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue571,300
Cost of Revenue-321,600
Gross Profit249,700249,700
 
Operating Income (+$)
Gross Profit249,700
Operating Expense-206,500
Operating Income43,20043,200
 
Operating Expense (+$)
Research Development53,100
Selling General Administrative32,662
Selling And Marketing Expenses120,691
Operating Expense206,500206,453
 
Net Interest Income (+$)
Interest Income815
Interest Expense-11,264
Other Finance Cost-775
Net Interest Income-9,674
 
Pretax Income (+$)
Operating Income43,200
Net Interest Income-9,674
Other Non-Operating Income Expenses0
Income Before Tax (EBT)30,10056,300
EBIT - interestExpense = 31,936
30,077
36,241
Interest Expense11,264
Earnings Before Interest and Taxes (EBIT)43,20041,364
Earnings Before Interest and Taxes (EBITDA)72,500
 
After tax Income (+$)
Income Before Tax30,100
Tax Provision-9,721
Net Income From Continuing Ops19,42820,379
Net Income24,977
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses528,100
Total Other Income/Expenses Net-13,1009,674
 

Technical Analysis of Boule
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Boule. The general trend of Boule is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Boule's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Boule Diagnostics AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 9.96 < 9.96 < 9.96.

The bearish price targets are: 9.14 > 9.05 > 8.81.

Tweet this
Boule Diagnostics AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Boule Diagnostics AB. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Boule Diagnostics AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Boule Diagnostics AB. The current macd is -0.06643827.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Boule price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Boule. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Boule price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Boule Diagnostics AB Daily Moving Average Convergence/Divergence (MACD) ChartBoule Diagnostics AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Boule Diagnostics AB. The current adx is 10.90.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Boule shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Boule Diagnostics AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Boule Diagnostics AB. The current sar is 9.170096.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Boule Diagnostics AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Boule Diagnostics AB. The current rsi is 45.17. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Boule Diagnostics AB Daily Relative Strength Index (RSI) ChartBoule Diagnostics AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Boule Diagnostics AB. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Boule price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Boule Diagnostics AB Daily Stochastic Oscillator ChartBoule Diagnostics AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Boule Diagnostics AB. The current cci is -36.93495039.

Boule Diagnostics AB Daily Commodity Channel Index (CCI) ChartBoule Diagnostics AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Boule Diagnostics AB. The current cmo is -12.07750381.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Boule Diagnostics AB Daily Chande Momentum Oscillator (CMO) ChartBoule Diagnostics AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Boule Diagnostics AB. The current willr is -48.7804878.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Boule is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Boule Diagnostics AB Daily Williams %R ChartBoule Diagnostics AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Boule Diagnostics AB.

Boule Diagnostics AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Boule Diagnostics AB. The current atr is 0.4369567.

Boule Diagnostics AB Daily Average True Range (ATR) ChartBoule Diagnostics AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Boule Diagnostics AB. The current obv is -1,177,081.

Boule Diagnostics AB Daily On-Balance Volume (OBV) ChartBoule Diagnostics AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Boule Diagnostics AB. The current mfi is 33.84.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Boule Diagnostics AB Daily Money Flow Index (MFI) ChartBoule Diagnostics AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Boule Diagnostics AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Boule Diagnostics AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Boule Diagnostics AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.168
Ma 20Greater thanMa 509.689
Ma 50Greater thanMa 1009.766
Ma 100Greater thanMa 20010.332
OpenGreater thanClose9.760
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Boule with someone you think should read this too:
  • Are you bullish or bearish on Boule? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Boule? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Boule Diagnostics AB

I send you an email if I find something interesting about Boule Diagnostics AB.


Comments

How you think about this?

Leave a comment

Stay informed about Boule Diagnostics AB.

Receive notifications about Boule Diagnostics AB in your mailbox!